Evaluate the Effect of Bone Marrow Derived Cd133+ Cells in Patient With Osteonecrosis of Femoral Head

Key facts

Sponsor

Royan Institute

Principal Investigator

Hamid Gourabi, PhD

Head of Royan Institute

Intervention

CD133+ cells(biological)

Enrollment

10 enrolled

Eligibility

18-65 years · All sexes

Timeline

2009 – 2013

Study locations (1)

• Royan Institute, Tehran, Iran

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Avascular necrosis

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNCT07286513
  Persona SoluTion PPS Femur PMCF
  Zimmer Biomet
• RECRUITINGPHASE2NCT06016634
  Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
  University of California, Davis
• RECRUITINGNANCT06823089
  Early Feasibility Study of Cartilage Defect Repair
  Cytex Therapeutics, Inc.
• RECRUITINGNANCT06631638
  EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
  DePuy Orthopaedics
• RECRUITINGNCT07104279
  Z1 Hip System: Post-Market Clinical Follow Up Study
  Zimmer Biomet
• ENROLLING BY INVITATIONNCT07150221
  MDR Vivacit-E Elevated Study
  Zimmer Biomet
• RECRUITINGNANCT07104084
  Influence of Antiseptic Washes on Wound Healing Complications After THA
  F. Johannes Plate
• ENROLLING BY INVITATIONNANCT07255768
  Comparison of the Efficacy of Pericapsular Nerve Group Block Alone Versus Pericapsular Nerve Group Block Combined With Superior Cluneal and Superior Gluteal Nerve Blocks in Patients Undergoing Hip Surgery
  Ataturk University

See all trials for Avascular necrosis →